Clinical Activity, Ultrasound Assessment and Drug Monitoring in Rheumatoid Arthritis Patients Receiving Anti-TNF-α Therapy with Extended Interval of Administration

被引：0

作者：

Miguel Senabre-Gallego, Jose ^{[1
]}

Rosas, Jose ^{[1
]}

Llinares-Tello, Francisca ^{[2
]}

Marco-Mingot, Mariana ^{[2
]}

Pons, Ana ^{[1
]}

Barber, Xavier ^{[3
]}

Santos-Soler, Gregorio ^{[1
]}

Salas-Heredia, Esteban ^{[1
]}

Cano, Catalina ^{[1
]}

Lorente, Marisa ^{[1
]}

Sanchis, Marina ^{[3
]}

Molina, Juan ^{[2
]}

Garcia-Carrasco, Mario ^{[4
]}

机构：

[1] Hosp Marina Baixa, Rheumatol, Villajoyosa, Alicante, Spain

[2] Hosp Marina Baixa, Villajoyosa, Alicante, Spain

[3] Univ Miguel Hernandez, CIO, Elche, Spain

[4] HGR 36 CIBIOR Inst Mexicano Seguro Social, Syst Autoimmune Dis Res Unit, Puebla, Mexico

来源：

ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

620

引用

页数：2

共 50 条

[31] Biological Anti-TNF-α Therapy and Markers of Oxidative and Carbonyl Stress in Patients with Rheumatoid Arthritis
Stenova, Emoke
Bakosova, Martina
Laukova, Lucia
Celec, Peter
Vlkova, Barbora
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2021, 2021
[32] Anti-TNF- therapy for rheumatoid arthritis among patients with chronic hepatitis B infection
Robinson, Helena
Walker-Bone, Karen
RHEUMATOLOGY, 2009, 48 (04) : 448 - 450
[33] NMR monitoring of rheumatoid arthritis patients receiving anti-TNF-alpha monoclonal antibody therapy
KaldenNemeth, D
Grebmeier, J
Antoni, C
Manger, B
Wolf, F
Kalden, JR
RHEUMATOLOGY INTERNATIONAL, 1997, 16 (06) : 249 - 255
[34] Periarticular bone changes in psoriatic and rheumatoid arthritis patients following anti-TNF-α therapy
Szentpetery, A.
Gallagher, P.
Van der Kamp, S.
McKenna, M. J.
Veale, D. J.
FitzGerald, O.
IRISH JOURNAL OF MEDICAL SCIENCE, 2011, 180 : S171 - S171
[35] Assessment of anti-TNF-α efficacy in rheumatoid arthritis:: is 3 months sufficient
Pocock, J. M.
Vasconcelos, J. C.
Oestoer, A. J. K.
RHEUMATOLOGY, 2008, 47 (07) : 1073 - 1076
[36] NATURAL AUTOANTIBODIES AGAINST CITRATE SYNTHASE AND DNA TOPOISOMERASE I IN PATIENTS WITH RHEUMATOID ARTHRITIS AND SPONDYLOARTHRITIS RECEIVING ANTI-TNF-α THERAPY
Simon, D.
Pusztai, A.
Najbauer, J.
Nemeth, P.
Szekanecz, Z.
Berki, T.
ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : A86 - A86
[37] CLINICAL USEFULNESS OF SERUM SOLUBLE ST2 IN RHEUMATOID ARTHRITIS WITH ANTI-TNF-α THERAPY
Kim, J. -J.
Choi, J. -I.
Joo, Y. -B.
Yoo, D. -H.
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 826 - 826
[38] NATURAL AUTOANTIBODIES AGAINST CITRATE SYNTHASE AND DNA TOPOISOMERASE I IN PATIENTS WITH RHEUMATOID ARTHRITIS AND SPONDYLOARTHRITIS RECEIVING ANTI-TNF-α THERAPY
Simon, D.
Pusztai, A.
Najbauer, J.
Nemeth, P.
Szekanecz, Z.
Berki, T.
ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 904 - 904
[39] Influence of anti-TNF-α infliximab therapy on adhesion molecules associated with atherogenesis in patients with rheumatoid arthritis
Gonzalez-Gay, M. A.
Garcia-Unzueta, M. T.
De Matias, J. M.
Gonzalez-Juanatey, C.
Garcia-Porrua, C.
Sanchez-Andrade, A.
Martin, J.
llorca, J.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2006, 24 (04) : 373 - 379
[40] The assessment of the cardiovascular risk in rheumatoid arthritis patients on anti TNF therapy
Anghel, Daniela
Petrache, Oana G.
Groseanu, Maria L.
Sirbu, Carmen A.
Opris-Belinski, Daniela
Radu, Florentine Ionita
ROMANIAN JOURNAL OF MILITARY MEDICINE, 2022, 125 (03) : 469 - 474

← 1 2 3 4 5 →